Abstract Staphylococcus aureus (SA) bacteriuria may accompany SA bacteremia, but primary SA urinary tract infection (UTI) may also occur. Our clinical observation of SA UTIs following intravenous catheter-related phlebitis lead us to review hematogenous and ascending route-related risk factors in patients with primary SA UTIs. The charts from all patients with SA UTIs over a 1.5-year period were reviewed for concurrent or recent hospitalization, intravenous catheterization, and for known UTI risk factors. Patients with concurrent SA bacteremia were excluded. Patients with Escherichia coli UTIs during the same period were included as controls. Twenty cases of primary SA UTI were compared with 43 E. coli UTI cases and they did not differ in age, diabetes mellitus, prostatic hypertrophy, previous UTI, or other urinary tract (UT) abnormality. However, cases were more likely than controls to have had recent or concurrent hospitalization, UT catheterization, and history of recent phlebitis. In multivariate analysis, UT catheterization and recent hospitalization retained significant association with SA UTI. Similar results were shown for the methicillinresistant SA UTI subgroup. Even though UT catheterization is the main predisposing factor for primary SA UTI, some cases may be mediated through unrecognized preceding bacteremia related to intravascular device exposure or other healthcare-related factors.
Introduction
Staphylococcus aureus (S. aureus, SA) is the causative factor of a great variety of infections in outpatients as well as in hospitalized patients. It is considered as one of the most common causes of nosocomial infection in US hospitals and in many European countries [1] . On the other hand, urinary tract infections (UTIs) are one of the most common types of infections encountered in clinical practice, while they constitute the most common type of nosocomial infection in the US [1] . Up to 95% of nosocomial UTIs may be associated with indwelling urinary catheters [1] .
Despite the above, S. aureus has been known for years to be a relatively rare urinary isolate [2] . Older studies, involving outpatients or inpatients or mixed populations, report a percentage of 0.5 to 6% of all positive urine cultures [3] [4] [5] [6] . Newer reports mention a 13.1% contribution of S. aureus in a bacteremic UTI case series involving mostly elderly people in a large community hospital [7] .
The clinical significance of a positive urine culture for SA has been long debated. Traditionally, S. aureus has been considered to invade the kidney from the hematogenous route, resulting in intrarenal or perinephric abscesses [6, 8] . S. aureus bacteriuria may occur in 7% of patients with S. aureus bacteremia and in 13% of cases of S. aureus endocarditis according to an older study [9] , although more recent data doubt this association [10] .
On the other hand, some investigators of S. aureus bacteremia include the urinary tract as the portal of entry, although infrequently [2] . In vitro, S. aureus is able to attach to and aggregate onto uroepithelial cells through glycoproteins found in bladder mucin, like GP51, which is significantly increased in the presence of UTI [11] . This retrograde pattern of S. aureus UTI (or primary SA UTI) has been mostly documented in elderly men with the presence of important predisposing factors in the urinary tract. These include the presence of indwelling catheters, obstruction or other abnormalities, instrumentation, or surgery [2, 4] . Rates of secondary bacteremia in these groups of patients have been reported to range from 2.3 to 8.3% [2, 4, 6, 12] .
Even more puzzling and also much less studied is the clinical significance of SA bacteriuria without documented bacteremia before or after the positive S. aureus urine culture date. A study of SA bacteriuria without documented bacteremia from 1997 speculates a transient unidentified bacteremic state, at least for some of these patients [13] . The above speculation of a transient bacteremic state leading to S. aureus urine colonization or even UTI (which, if it existed, would possibly be another candidate for the definition of "primary SA UTI" besides the already known UTI via the ascending route) could potentially apply to some clinical observations that we made in our clinical practice: -Case report A: A young woman with eosinophilic meningitis and prolonged hospital stay was seen in follow-up with a superficial phlebitis at the site of a previous intravenous catheter in her wrist/forearm. The site was not warm or fluctuant and she had no systemic symptoms, so she was treated conservatively with warm compresses. The following visit, she mentioned symptoms of a UTI, so a urinalysis (UA) and a urine culture (UC) were sent and she was started on trimethoprim-sulfamethoxazole empirically. The UC yielded >10 5 colonies/ml of S. aureus (pure growth). -Case report B: A 42-year-old patient with advanced AIDS and HIV-related dementia was hospitalized briefly for mental status changes. During his hospital stay, he received a brief course of intravenous anti-CMV therapy. The hospital course was uneventful, he improved and was discharged home after 8 days. There was no UT manipulation during his hospital stay or later and there was no history of UTI or UT abnormality. Four weeks later, he was evaluated as an outpatient. He had no systemic symptoms but reported new-onset urinary frequency, dysuria, and suprapubic pain. UA showed significant pyuria and UC revealed pure growth of >10 5 colonies/ml of S. aureus.
We hypothesized that the "primary S. aureus UTI" identified in those two patients was blood-borne in origin. In the first case, it could be related to transient bacteremia related to intravenous site thrombophlebitis, while in the second case, there was no obvious primary focus, but the patient had been recently hospitalized, received intravenous therapy, and was significantly immunocompromised. Several reports of increased rates of S. aureus bacteremia in the HIV/AIDS population are now available [14, 15] .
Materials and methods
To put our hypothesis in perspective, we wanted to further evaluate the occurrence of this phenomenon/syndrome, should it exist. Our study was approved by the Institutional Review Board (IRB) of Northwestern University and Lakeside Veterans Affairs (VA) Hospital.
We used the infection control records of the VA hospital for the purposes of our research. We reviewed the infection control line listing of patients with S. aureus infections of the time period between March 2000 and September 2001 and we identified patients with positive urine cultures for S. aureus without documented concurrent S. aureus bacteremia. Then, we used the computerized medical record system of our hospital to search the charts of those patients for clinical and microbiological data to support the diagnosis of "SA symptomatic UTI without concurrent bacteremia".
The diagnosis of "symptomatic UTI" was present when all of the following criteria were present: (1) positive urine culture for S. aureus in pure growth and >10 5 CFU/mL; (2) more than ten white blood cells per high-power field on urinalysis; (3) positive test for nitrates or leucocyte esterase; (4) at least four out of the following six symptoms/signs: dysuria, frequency, hematuria, fever more than 38°C, suprapubic tenderness, costovertebral area tenderness to percussion; and (5) diagnosis of UTI by the responsible physicians.
"Concurrent bacteremia" was defined as at least one blood culture positive for S. aureus in the 2 weeks preceding or the 72 h after the first urine culture yielding S. aureus.
By using the above-described definitions, we finally ended up with a list of 20 patients eligible for further study.
For those 20 patients, we collected demographic and medical history data about pre-existing illnesses (with attention to conditions predisposing to UTI). We recorded data about prior hospitalization within the last 6 months and inpatient or outpatient status when the UC was obtained. Paper chart notes were also reviewed looking for history of recent hospitalization at another facility possibly not recorded on the electronic VA chart.
Dates of prior vascular procedures (peripheral line and/or central venous catheter placement) that took place during the last month before the positive UC date were also recorded. Subsequently, we carefully reviewed all of the medical and nursing notes up to 1 month prior to the positive UC date looking for any sign of local inflammation at the site of the peripheral or central catheter entry. We included recordings about local redness, swelling, induration, and the presence of pus.
Additionally, we looked for data on any kind of UT manipulation during the same time period. This included the placement and presence of a Foley catheter up to 48 h before the positive UC date and also other urologic procedures.
To compare that patient group ("SA group" or "cases") with other primary UTI cases in which retrograde infection is usually the norm, we looked for a control group of E. coli UTI cases without concomitant bacteremia. The exclusion of bacteremic E. coli UTI cases may not have been critical, as most E. coli bacteremias are thought to be secondary to E. coli UTI and much less likely due to other primary foci of infection.
We reviewed our microbiology laboratory records for E. coli urinary isolates and identified cases of positive UCs for E. coli without documented concurrent bacteremia for the same time period (March 2000 through September 2001).
We went through the exact same procedure as for the SA group (review of computerized medical charts to support the diagnosis of "E. coli symptomatic UTI without concurrent bacteremia" based on identical definitions to those for SA UTI). After eliminating from our list patients not fitting the pre-specified criteria, we created our control group (almost double in number compared to the SA cases) by selecting every third eligible case from the modified microbiology list. Finally, we went back to computerized and paper medical charts and collected similar data for our control group as for the SA patients.
Statistical analysis
The collected data were entered into a Microsoft Excel spreadsheet and version 13 of the SPSS software was used for the data processing. 
Results and discussion
We were finally able to compare 20 cases of S. aureus symptomatic UTI with a control group of 43 E. coli symptomatic UTI cases. The characteristics of the S. aureus group and the E. coli control group are shown in Table 1 .
Cases (n=20) and controls (n=43) were similar with respect to age (71.15±11.6 vs. 67.9±13.5 years, mean ± SD), diabetes mellitus (35% vs. 31%), prostatic hypertrophy (50% vs. 48%), previous UTI (25% vs. 26%), and other UT abnormality (15% vs. 21%). However, cases were more likely than controls to have had recent hospitalization (within the last 6 months) and recent urinary catheterization (p-values of 0.012 and 0.0001, respectively). Additionally, cases exhibited a trend, as a group, for having had central line placement the month before the positive UC date (p = 0.075) and were also more likely to have exhibited signs of inflamed peripheral intravenous line within the same time period (p = 0.008). In multivariate analysis, recent urinary catheterization and history of admission during the last 6 months for outpatients remained significant predictors of SA UTI (p = 0.000 and 0.006, respectively).
We then attempted to compare each of the two subgroups of the SA UTI cases (MRSA and MSSA) with the control cases in a similar manner (Table 1) .
MRSA cases
Cases of MRSA UTI (n=15) did not differ from controls in terms of age, diabetes mellitus, prostatic hypertrophy, previous UTI, and other UT abnormality (15% vs. 21%).
Strong differences again arose between MRSA cases and controls when assessed for hospitalization within the last 6 months (p = 0.013) and recent urinary catheterization (p = 0.000). Additionally, MRSA cases were more likely to have been inpatients on the date of the positive culture 
MSSA cases
That small subgroup again did not differ from controls in terms of age, diabetes mellitus, prostatic hypertrophy, previous UTI, and other UT abnormality. Also, no significant differences were noted in any parameter which differed in the previous group analyses, possibly due to the low numbers, at least in part.
Even though several types of infectious syndromes caused by S. aureus are common in clinical practice and adequately well studied, urinary tract involvement by this pathogen is probably not one of them. The presence of S. aureus in urine cultures is not always easy either to explain or to appreciate its significance in order to evaluate and treat accordingly. The long-standing concept of SA bacteriuria as a common reflection of SA bacteremia has been cast doubt, even for patients without recent indwelling urinary catheter placement, in terms of the cost-effectiveness of extensive source investigations [10, 13] . The authors of the 1997 report do not think an extensive evaluation for an occult focus of S. aureus infection is warranted for patients with SA bacteriuria, although it should be considered with communityacquired SA bacteriuria, pure growth of >10 8 organisms/ L in culture, and the absence of urinary tract predisposing conditions (mentioned above) [13] .
On the other hand, S. aureus seems to be an infrequent but definite colonizer of the urinary tract, especially in people with urinary catheters, and, in a minority of those, a cause of symptomatic UTI [12] . Although urinary S. aureus may be the source of subsequent staphylococcal bacteremia, the proportion of patients with chronic S. aureus bacteriuria who subsequently become bacteremic is unknown [12] .
Our two clinical cases prompted us to investigate another -probably-piece of the puzzle: the circumstances of development of symptomatic UTI by S. aureus in the absence of documented bacteremia. Our hypothesis was that these circumstances could involve, besides prior urinary tract manipulation leading to SA colonization, a transient bacteremic state, at least for some of the cases, like Sheth and DiNubile speculated in 1997 [13] . We carefully identified patients with the diagnosis of SA UTI without documented preceding or concomitant bacteremia based on strict predefined criteria and compared them with a control group of E. coli UTI patients in terms of predisposing factors for ascending SA UTI, as well as predisposing factors for preceding SA bacteremia, focusing especially on exposure to the healthcare system and the recent presence of intravascular devices.
The results of our study were in agreement with other reports that urinary catheterization is probably the strongest predisposing factor for colonization and/or infection of the UT by S. aureus. Besides that, it did bring up-in our opinion-some interesting hints that other factors related to exposure to the healthcare system may be participating in the process, possibly through transient unrecognized bacteremia, at least in some instances. The SA group had higher rates of recent hospitalization, recent central venous catheter placement, and recent line-related peripheral thrombophlebitis. The noticed trend was largely driven by the MRSA patients. There were significantly more inpatients included in the MRSA subgroup than in the control group and they did have higher rates of intravascular device placement preceding the UTI by S. aureus. Additionally, recent hospitalization maintained its significant difference in multivariate analysis between that subgroup and the E. coli control group, the latter not without significant exposure to both UT manipulations and the healthcare system. Transient, sometimes asymptomatic and spontaneously resolving S. aureus bacteremia, is a well-known phenomenon to experienced clinicians but is not adequately studied. Any attempt to further study that phenomenon in a prospective way would probably be unethical, especially when thinking of how devastating S. aureus bloodstream infection can be to the point that even the finding of colonization of a removed intravascular catheter without documented bacteremia may warrant immediate antistaphylococcal therapy [16] . Nevertheless, some studies have touched on that issue from different angles. In an older prospective study of sources and outcome of MRSA bacteremia and septicemia (total of 82 episodes), circulation access sites were the most common source of the bacteremia, with non-surgical wounds, including burns, varicose ulcers, and bed sores as the next most common [17] . The authors categorized 15 of those episodes of bacteremia as transient and, even though they did not provide exact details, they mentioned that 14 of the 82 episodes resolved without antimicrobial therapy. Patients with transient bacteremia were relatively younger than patients with septicemia. The two groups did have, however, similar rates of serious underlying diseases and recent surgery. In 10% of cases, there was no obvious source for bacteremia. In three cases, there had been recent surgery, while four of the remaining five patients had been recently receiving intravenous fluids. S. aureus can be an infrequent cause of transient bacteremia after tooth surgery [18] and also after both upper and lower gastrointestinal endoscopy, where it has been long realized that bacteremia is usually transient and asymptomatic [19] .
Interestingly, the small MSSA UTI group seemed also to have had its share of healthcare and intravascular device exposure, despite no detected difference in inpatient status on the culture date. Also, no difference arose in the urinary catheterization rates when compared with the E. coli group. More definite conclusions about that group were precluded by its small size.
Strengths of the study
We have not found any prior studies addressing this specific question. We tried our best to apply strict criteria for patient enrollment in the study. The study group was derived from a significantly homogeneous population in terms of demographics and underlying illnesses. A significant degree of homogeneity also holds true about the completeness of medical care data for the population, based on the almost exclusive care at the VA hospital, computerized medical records, and the full availability of nursing records. Additionally, we carefully created a control group of E. coli UTI cases based on the same criteria for more accurate comparison purposes. Finally, although we can only speculate that our hypothesis may be true under certain circumstances and in certain patients, we believe in our results since they seem to be making physiologic sense in terms of what is known about the epidemiology and clinical behavior of S. aureus.
Limitations of the study
There was obviously no definite conclusion of a new pathogenetic pathway for S. aureus symptomatic UTI from our retrospective study. Despite our efforts for completeness, we definitely had missing data on hospitalization events, urinary tract instrumentation, and intravascular device use. Still, we believe that, if the data were even more complete, it would have augmented possible differences between the study groups. Along the same line, we did not assess other risk factors for S. aureus bacteremia (surgery, etc.). Additionally, since (a) there is significant symptom overlap between cystitis, prostatitis, and pyelonephritis and (b) the diagnosis documented in the patient charts was, in the majority of cases, just "urinary tract infection" without further specification, our data were not accurate enough to discriminate between upper and lower UTI in the two groups. That is why we maintained the general term "symptomatic urinary tract infection" throughout. Furthermore, we did not obtain the outcome data of our study patients. A recent well-designed study reported worse outcomes in those cases of S. aureus bacteremia accompanied by bacteriuria [20] . Finally, the patient numbers were small, especially that of the MSSA UTI subgroup.
We conclude that, even though urinary tract catheterization is probably the strongest predisposing factor for primary S. aureus UTI, some cases may be mediated through another pathogenetic mechanism, i.e., unrecognized preceding bacteremia related to intravascular device exposure or other healthcare-related factors. We are not sure if a larger, prospective study could clarify this issue. Still, we believe that clinicians treating patients with S. aureus UTI should thoroughly inquire both about recent UT instrumentation and recent hospitalization with intravascular device use.
